share_log

CASI Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Huang(19.99%),Panacea Venture Healthcare Fund II, L.P.(19.31%), etc.

CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(19.99%),Panacea Venture Healthcare Fund II, L.P.(19.31%)等

美股SEC公告 ·  01/26 08:34
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息